Dr. Byrd is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
521 B Moye Blvd 2nd floor
ECU Physicians Internal Medicine Moye Medical Center 1
Greenville, NC 27834Phone+1 252-744-3229Fax+1 252-744-3924
Education & Training
Boston University Medical CenterResidency, Internal Medicine, 1982 - 1984
University of Vermont Medical CenterResidency, Internal Medicine, 1978 - 1982
University of Minnesota Medical SchoolClass of 1978
Certifications & Licensure
NC State Medical License 1995 - 2025
WI State Medical License 1984 - 1995
VT State Medical License 1980 - 1983- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 28 citationsLow expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cellsMatthias Ilmer, Nachman Mazurek, Michael Z. Gilcrease, James C. Byrd, Wendy A. Woodward
Breast Cancer Research. 2016-09-29 - 22 citationsCell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics.Matthias Ilmer, Nachman Mazurek, James C. Byrd, Karen Ramirez, Margarete Hafley
Cell Death & Disease. 2016-08-11 - 77 citationsCell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.Nachman Mazurek, James C. Byrd, Yunjie Sun, Margarete Hafley, Karen Ramirez
Cell Death and Differentiation. 2012-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
